Biological activities of emetine

Open Natural Products Journal

Volumn 4, Issue , 2011, Pages 8-15

  Akinboye, Emmanuel S ^a   Bakare, Oladapo ^a  

^a HOWARD UNIVERSITY   (United States)

Author keywords

Alkaloid; Biological activity; DNA; Emetine; Entamoeba histolytica; Ipecac; Protein synthesis; RNA

Indexed keywords

AZACITIDINE; CISPLATIN; CYCLOPHOSPHAMIDE; DNA; DOCETAXEL; DOXORUBICIN; EMETINE; ETOPOSIDE; GLYCOPROTEIN P; OXALIPLATIN; RHODAMINE 123; TRICHOTHECENE;

ANTINEOPLASTIC ACTIVITY; ANTIPARASITIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CANCER CELL CULTURE; COMBINATION CHEMOTHERAPY; CONTRACEPTION; DNA SYNTHESIS; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG STRUCTURE; ENTAMOEBA HISTOLYTICA; HUMAN; LUNG CANCER; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RISK REDUCTION; RNA SYNTHESIS; UPREGULATION;

EID: 79955051953     PISSN: None     EISSN: 18748481     Source Type: Journal    
DOI: 10.2174/1874848101104010008     Document Type: Article

References (88)

1. Wiegrebe, W.; Kramer, W.J.; Shamma, M. The emetine alkaloids. J. Nat. Prod., 1984, 47, 397-408.
2. Garcia, R. M. A.; Oliveira, L. O.; Moreira, M. A.; Barros, W. S. Variation in emetine and cephaeline contents in roots of wild ipecac (psychotria ipecacuanha). Biochem. Syst. Ecol., 2005, 33, 233-243.
3. Battersby, A.R.; Openshaw, H.T.; Wood, H.C.S. The constitution of emetine. Cell. Mol. Life Sci., 1949, 5, 114-115.
4. Battersby, A.R.; Openshaw, H.T. Further evidence regarding the structure of emetine. Cell Mol. Life Sci., 1949, 5, 398.
5. Battersby, A.R.; Binks, R.; Lawrie, W.; Parry, G.V.; Webster, B.R. Alkaloid biosynthesis. Part IX. The ipecacuanha alkaloids. J. Chem. Soc., 1965, 7459-7468.
6. Grollman, A.P. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics. Proc. Natl. Acad. Sci. USA, 1966, 56, 1867-1874
7. Zhou, Y.D.; Kim, Y.P.; Mohammed, K.A.; Jones, D.K.; Muhammad, I.; Dunbar, D.C.; Nagle, D.G. Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells. J. Nat. Prod., 2005, 68, 947-950
8. Gupta, R.S.; Krepinsky, J.J.; Siminovitch, L. Structural determinants responsible for the biological activities of (-)-emetine, (-)- cryptopleurine, and (-)-tylocrebrine: structure-activity relationship among related compounds. Mol. Pharmacol., 1980, 18, 136-143
9. Troconis, M.; Ma, W.; Nichols, D.E.; McLaughlin, J. Molecular modeling study of tubulosine and other related ipecac alkaloids. J. Comput. -Aided Mol. Des., 1998, 12, 411-418.
10. Grollman, A.P. Inhibitors of protein biosynthesis V. Effects of emetine on protein and nucleic acid biosynthesis in HeLa cells. J. Biol. Chem., 1968, 243, 4089-4094.
11. Gupta, R.S.; Louis Siminovitch, L. The isolation and preliminary characterization of somatic cell mutants resistant to the protein synthesis inhibitor-emetine. Cell, 1976, 9, 213-219.
12. Jimenez, A.; Carrasco, L.; Vazquez, D. Enzymic and nonenzymic translocation by yeast polysomes. Site of Action of a number of inhibitors. Biochemistry, 1977, 16, 4727-4730
13. Lietman, P.S. Mitochondrial protein synthesis: Inhibition by emetine hydrochloride. Mol. Pharmacol., 1970, 7, 122-128.
14. Gilead, Z.; Becker, Y. Effect of emetine on ribonucleic acid biosynthesis in HeLa cells. Eur. J. Biochem., 1971, 23, 143-149.
15. Cashman, T.M.; Conklin, K.A.; Chou, S.C. The effects of emetine on macromolecular synthesis in synchronized Tetrahymena pyriformis. Cell. Mol. Life Sci., 1972, 28, 520-521.
16. Beller, B.M. Observations on the mechanism of emetine poisoning of myocardial tissue. Circ. Res., 1968, 22, 501-505.
17. Chatterjee, A.K.; Roy, A.D.; Dutta, S.C.; Ghosh, B.B. Effect of emetine on certain aspect of protein metabolism. Experientia, 1970, 26, 1077-1078
18. Watanabe, N.; Shimada, H. Effects of emetine on initiation of DNA synthesis in embryonic cells of sea urchin. Cell Differ., 1983, 13, 239-245.
19. Nikolaenko, V.N. Maintenance of homeostasis of endogenous ethanol as a method for the therapy of alcoholism. Bull. Exp. Biol. Med., 2001, 131, 231-233.
20. Kovács, J.; Rez, G. Prevention of induced autophagy by emetine in exocrine cells of mouse pancreas and seminal vesicle. Virchows Arch. Abt. B Zellpath., 1974, 15, 209-216.
21. Schweighoffer, T.; Schweighoffer, E.; Apati, A.; Antoni, F.; Molnar, G.; Lapis, K.; Banfalvi, G. Cytometric analysis of DNA replication inhibited by emetine and cyclosporin A. Histochemistry, 1991, 96, 93-97.
22. Antoni, F.; Luat, N.N.; Csuka, I.; Oláh, I.; Soóki-Tóth, A.; Bánflavi, G. The immunosuppressive effect of acute doses of emetine on murine thymic cells. Int. J. Immunopharmacol., 1987, 9, 333-340.
23. Vedder, E.B. An experimental study of the action of ipecacuanha on amoebae. J. Trop. Med. Hyg., 1912, 15, 313-314
24. Thompson, J.H.C. The treatment of dysentery by injection of emetine hydrochloride. Dub. J. Med. Sci., (1872-1920), 1913, 136, 102-109.
25. Lambert, A.C.; Toronto, C.M. The treatment of amoebic dysentery with emetine and bismuth iodide. Br. Med. J., 1918, 1, 116-118.
26. Johnson, R.L.; Rogers, J.W.; Zinneman, H.H. Amebic Liver Abscess. Dig. Dis. Sci., 1968, 13, 822-829.
27. Ruiz-Moreno, F. Perianal skin amebiases. Dis. Colon Rectum., 1967, 10, 65-69.
28. Lasserre, R. Treatment of amebiasis. Philos. J. Microbiol. Infect. Dis., 1979, 8, 1-6.
29. Villalba-Magdaleno, J.D.; Rojas, R.; Gomez, C.; Shibayama, M.; Carrero, J.C.; Ishiwara, D.G.P. Emetine produce Entamoeba histological death by inducing a programmed cell death. Am. J. Infect. Dis., 2007, 3, 110-114.
30. Muhammad, I.; Dunbar, D.C.; Khan, S.I.; Tekwani, B.L.; Bedir, E.; Takamatsu, S.; Ferreira, D.; Walker, L.A. Antiparasitic alkaloids from Psychotria klugii. J. Nat. Prod., 2003, 66, 962-967.
31. Konopka, E.A.; Goble, F.C.; Prins, D.A. Emetine and some related compounds in experimental Chaga's disease. Antimicrob. Agents Chemother., 1965, 772-776.
32. Cavin, J.C.; Krassner, S.M.; Rodriguez, E. Plant-derived alkaloids active against Trypanosoma cruzi. J. Ethnopharmacol., 1987, 19, 89-94.
33. Mackey, Z.B.; Baca, A.M.; Mallari, J.P.; Apsel, B.; Shelat, A.; Hansell, E.J.; Chiang, P.K.; Wolff, B.; Guy, K.R.; Williams, J.; McKerrow, J.H. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chem. Biol. Drug Des., 2006, 67, 355-363.
34. Rosenkranz, H.; Wink, M. Alkaloids induced programmed cell death in bloodstream forms of Trypanosomes (Trypanosoma b. bruices). Molecules, 2008, 13, 2462-2473.
35. Merschjohann, K.; Sporer, F.; Steverding, D.; Wink, M. In vitro effects of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense. Planta Med., 2001, 67, 623-627.
36. Shahlapour, A.A.; Eslami, A.H.; Eliazian, H. Comparative anthelmintic tests in sheep and goats infected with gastro-intestinal nematodes and lungworms in Iran. Trop. Anim. Health Prod., 1970, 2, 223-234.
37. Deng, L.; Dai, P.; Ciro, A.; Smee, D.F.; Djaballah, H.; Shuman, S. Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly. J. Virol., 2007, 18, 13392-13402.
38. Low, Y.J.S.; Chen, K.C.; Wu, K.X.; Mah-Lee Ng, M.; Chu, H.J.J. Antiviral activity of emetine dihydrochloride against dengue virus infection. J. Antivir. Antiretrovir., 2009, 1, 62-71.
39. Lewisohn, R. Action of emetine on malignant tumors. J. Am. Med. Assoc., 1918, 70, 9-10.
40. Van Hoose, B. Emetine hydrochloride in malignancy. Women's Med. J., 1919, 29, 102-116.
41. Jondorf, W.R.; Abbott, B.J.; Greenberg, N.A.; Mead, J.A.R. Antileukemic effectiveness of (-)-emetine and some of its derivatives. Pharmacologist, 1970, 12, 282.
42. Panettiere, F.; Coltman, C.A, Jr. Phase I experience with emetine hydrochloride (NSC 33669) as an antitumor agent. Cancer, 1971, 27, 835-841.
43. Mastrangelo, M.J.; Grage, T.B.; Bellet, R. E.; Weiss, A.J. A phase I study of emetine hydrochloride (NSC 33669) in solid tumors. Cancer, 1973, 31, 1170-1175.
44. Siddiqui, S.; Firat, D.; Olshin, S. Phase II study of emetine (NSC- 33669) in the treatment of solid tumors. Cancer Chemother. Rep., 1973, 57, 423-428.
45. Moertel, C.G.; Schutt, A.J.; Hahn, R.G.; Reitemeier, R.J. Treatment of advanced gastrointestinal cancer with emetine (NCS-33669). Cancer Chemother. Rep., 1974, 58, 229-232.
46. Kane, R.C.; Cohen, M.H.; Broder, L.E.; Bull, M.I.; Creaven, P.J.; Fossieck, B.E, Jr. Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma. Cancer Chemother. Rep., 1975, 59, 1171-1172.
47. Bicknell, G.R.; Snowden, R.T.; Cohen, G.M. Formation of high molecular mass of DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937. J. Cell Sci., 1994, 107, 2483-2489.
48. Watanabe, N.; Iwamoto, T.; Dickinson, D.A.; Iles, K.E.; Forman, H.J. Activation of the mitochondrial caspase in the absence of rotein synthesis does not require c-Jun N-terminal kinase. Arch. Biochem. Biophys., 2002, 405, 231-240.
49. Moller, M.; Weiss, J.; Wink, M. Reduction of cytotoxicity of the alkaloid emetine through P-glycoprotein (MDR1/ABCB1) in human caco-2 and leukemia cell lines. Planta Med., 2006, 72, 1121-1126.
50. Meijerman, I.; Blom, W.M.; de Bont, H.J.G.M.; Mulder, G.J.; Nagelkerke, J.F. Induction of apoptosis and changes in nuclear Gactin are mediated by different pathways: the effects of inhibitors of protein and RNA synthesis in isolated rat hepatocytes. Toxicol. Appl. Pharmacol., 1999, 156, 46-55.
51. Boon-Unge, K.; Yu, Q.; Zou, T.; Zhou, A.; Govitrapong, P.; Zhou, J. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatidase 1- dependent mechanism. Chem. Biol., 2007, 14,1386-1392.
52. Moller, M.; Herzer, K.; Wenger, T.; Herr, I.; Wink, M. The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells. Oncol. Rep., 2007, 18, 737-744.
53. Moller, M.; Wink, M. Characteristics of apoptosis induction by the alkaloid emetine in human tumor cell lines. Planta Med., 2007, 73, 1389-1396.
54. Sampieri, C.L.; Nuttall, R.K.; Young, D.A.; Goldspink, D.; Clark, I.M.; Edward, D.R. Activation of p38 and JNK MAPK pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes. Matrix Biol., 2008, 27, 128-138.
55. Arany, Z.; Wagner, B.K.; Ma, Yanhong.; Chinsomboon, J.; Laznik, D.; Spiegelman, B.M. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1 and oxidative phosphorylation. Proc. Natl. Acad. Sci. USA, 2008, 105, 4721-4726.
56. Zhang, Y.; Ba, Y.; Liu, C.; Sun, G.; Ding, L.; Gao, S.; Hao, J.; Yu, Z.; Zhang, J.; Zen, K.; Tong, Z.; Xiang, Y.; Zhang, C-Y. PGC-1α induces apoptosis in human epithelial ovarian cancer cells through a PPARγ-dependent pathway. Cell Res., 2007, 17, 363-373.
57. Street, E.W. Cyclophosphamide plus emetine in lung cancer. Lancet, 1972, 300, 381-382.
58. Sautkina, E.N.; Potapenko, N.A.; Vladimirova, N.M. State of nucleolar proteins B23/nucleophosmin and UBF in HeLa cells during apoptosis induced by tumor necrosis factor. Biochemistry (Moscow), 2006, 71, 634-643.
59. Gasparian, M.E.; Ostapchenko, V.G.; Yagolovich, A.V.; Tsygannik, I.N.; Chernyak, B.V.; Dolgikh, D.A.; Kirpichnikov, M.P. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase. Biotechnol. Lett., 2007, 29, 1567-1573.
60. Larsson, D.E.; Hassan, S.; Larsson, R.; Oberg, K.; Granberg, D. Combination analysis of anti-cancer drugs on human neuroendocrine tumor cell lines. Cancer Chemother. Pharmacol., 2009, 65, 5-12.
61. Li, W.; Venkataraman, G.M.; Ain, K.B. Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor. J. Clin. Endocrinol., 2007, 92, 1080-1087.
62. Giaccia, A.; Siim, B.G.; Johnson, R.S. HIF-1 as a target for drug development. Nat. Rev. Drug Discov., 2003, 2, 803-811.
63. Bachovchin, D.A.; Brown, S.J.; Rosen, H.; Cravatt, B.F. Identification of selective inhibitors of uncharacterized enzymes by ighthroughput screening with fluorescent activity-based probes. Nat. Biotechnol., 2009, 27, 387-394.
64. Neznanov, N.; Gorbachev, A.V.; Neznanova, L.; Komarov, A.P.; Gurova, K.V.; Gasparian, A.V.; Banerjee, A.K.; Almasan, A.; Fairchild, R.L.; Gudkov, A.V. Anti-malaria drug blocks proteotoxic stress response: anticancer implications. Cell Cycle, 2009, 8, 3960-3970.
65. Leatherman, D.L.; Middlebrook, J.L. Effects of emetine on the specific association of T-2 toxin with mammalian cells. J. Pharmacol. Exp. Ther., 1993, 266, 732-740.
66. Leatherman, D.L.; Middlebrook, J.L. Effects of emetine on T-2 toxin-induced inhibition of protein synthesis in mammalian cells. J. Pharmacol. Exp. Ther., 1993, 266, 741-748.
67. Moyer, D.L.; Thompson, R.S.; Berger, I. Anti-implantation action of a medicated intrauterine delivery system (MIDS). Contraception, 1977, 16, 39-49.
68. Mehrotra, P.K.; Kitchlu, S.; Dwivedi, A.; Agnihotri, P.K.; Srivastava, S.; Roy, R.; Bhaduri, A.P. Emetine ditartrate: a possible lead for emergency contraception. Contraception, 2004, 69, 379-387.
69. Mercola, D.; Welsh, J. From mRNA to tumor suppressor. Nat. Genet., 2004, 36, 937-938.
70. Noensie, E.N.; Dietz, H.C. A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat. Biotechnol., 2001, 19, 434-439.
71. Huusko, P.; Ponciano-Jackson, D.; Wolf, M.; Kiefer, J.A.; Azorsa, D.O.; Tuzmen, S.; Weaver, D.; Robbins, C.; Moses, T.; Allinen, M.; Hautaniemi, S.; Chen, Y.; Elkahloun, A.; Basik, M.; Bova, G.S.; Bubendorf, L.; Lugli, A.; Sauter, G.; Schleutker, J.; Ozcelik, H.; Elowe, S.; Pawson, T.; Trent, J.M.; Carpten, J.D.; Kallioniemi, O, Mousses, S. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat. Genet., 2004, 36, 979-983.
72. Ionov, Y.; Nowak, N.; Perucho, M.; Markowitz, S.; Cowell, J.K. Manipulation of nonsense mediated decay identifies gene mutations in colon cancer cells with microsatellite instability. Oncogen, 2004, 23, 639-645.
73. Bloethner, S.; Mould, A.; Stark, M.; Hayward, N.K. Identification of ARHGEF17, DENND2D, FGFR3, and RBI mutations in melanoma by inhibition of nonsense-mediated mRNA decay. Gene Chromosome Cancer, 2008, 47, 1076-1085.
74. Hopf, N.J.; Goebel, H.H. Experimental emetine myopathy: enzyme histochemical, electron microscopic, and immunomorphological studies. Acta Neuropathol., 1993, 85, 414-418.
75. Pan, S.J.; Combs, A.B. Effects of pharmacological intervention on emetine cardiotoxicity in isolated perfused rat hearts. Toxicology, 1995, 97, 93-104.
76. Pan, S.J.; Combs, A.B. Emetine inhibits glycolysis in isolated, perfused rat hearts. Cardiovasc. Toxicol., 2003, 3, 311-318.
77. Keiser, M.J.; Roth, B.L.; Armbruster, B.N.; Ernsberger, P.; Irwin, J.J.; Shoichet, B.K. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol., 2007, 25, 197-206.
78. Abd-Rabbo, H. Dehydroemetine in chronic leukaemia. Lancet, 1966, 287, 1161-1162.
79. Abd-Rabbo, H. Chemotherapy of neoplasia (cancer) with dehydroemetine. J. Trop. Med. Hyg. 1969, 72, 287-290.
80. Wyburn-Mason, R. Dehydroemetine in chronic leukaemia. Lancet, 1966, 287, 1266-1267.
81. Suffness, M.; Douros, J. In: Anticancer Agents Based on Natural Product Models, Cassady, Douros, Ed.; Academic Press Medicinal Chemistry: New York, 1980; Vol. 16, pp. 465-487.
82. Gradnik, B.; Dall'asta, L.; Pedrazzoli, A. Amebicides. l-emetine derivatives. J. Med. Chem., 1971, 14, 255-256.
83. Borgnia, M.J.; Eytan, G.D.; Assaraf, Y.G. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophores as revealed by its ATPase activity. J. Biol. Chem., 1996, 271, 3163-3171.
84. Samuelson, J.; Ayala, P.; Orozco, E.; Wirth, D. Emetine-resistance mutants of Entamoeba histolytica overexpress mRNAs for multidrug resistance. Mol. Biochem. Parasitol., 1990, 38, 281-290.
85. Gant, T.W.; Silverman, J.A.; Thorgeirsson, S.S. Regulation of Pglycoprotein gene expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor. Nucleic Acids Res., 1992, 20, 2841-2846.
86. Descoteaux, S.; Ayala, P.; Samuelson, J.; Orozco, E. Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene, 1995, 164, 179-184.
87. Ghosh, S.K.; Lohia, A.; Kumar, A.; Samuelson, J. Overexpression of P-glycoprotein gene 1 by transfected Entamoeba histolytica confers emetine-resistant. Mol. Biochem. Parasitol., 1996, 82, 257-260.
88. Pires, M.M.; Hrycyna, C.A.; Chmielewski, J. Bivalent probes of the human multidrug transporter P-glycoprotein. Biochemistry, 2006, 45, 11695-11702.